• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估甲状腺乳头状癌患者的 ABO/Rh 血型分布。

Evaluation of ABO/Rh blood group distributions in papillary thyroid cancer patients.

机构信息

Health Sciences University, Haseki Training and Research Hospital, Department of Endocrinology, Fatih, Istanbul, Turkey.

出版信息

Medicine (Baltimore). 2023 Aug 11;102(32):e34564. doi: 10.1097/MD.0000000000034564.

DOI:10.1097/MD.0000000000034564
PMID:37565904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10419498/
Abstract

The study aimed to evaluate the ABO/Rh blood group distributions and their relationship with clinical-pathological features in papillary thyroid cancer patients. It was planned as a retrospective case-controlled study. The blood group distributions of the patients were contrasted with that of the general population. Additionally, the association between clinical-pathological variables and blood group distribution was assessed. Two hundred and ninety-three patients were involved in the study. The median age was 48 years, and the majority of patients were female (84.3%). The most common variants of papillary thyroid cancer were follicular, classical, and oncocytic. The majority of the patients had stage 1 (91.1%) disease at the time of diagnosis. ABO blood group distributions in the patient (47.4% A, 11.9% B, 8.2% AB, 32.4% O) and control (42% A, 16% B, 8% AB, 34% O) groups were found to be similar ( P = .8). In terms of Rh factor, there was a comparable distribution for the characteristics of the patient and healthy control group ( P = .6). There was no association between clinical and pathological variables and blood group distributions (gender, age, tumor stage, tumor location, and pathological tumor variant). Comparing patients with papillary thyroid carcinoma to the healthy control group, the prevalence of the A blood group numerically increased while the prevalence of the B blood group numerically decreased, but it was not statistically significant. In addition, ABO/Rh blood type and clinical and pathological variables did not relate.

摘要

本研究旨在评估 ABORh 血型分布及其与甲状腺乳头状癌患者临床病理特征的关系。该研究计划采用回顾性病例对照研究。将患者的血型分布与普通人群进行对比。此外,还评估了临床病理变量与血型分布之间的关系。该研究共纳入 293 例患者。中位年龄为 48 岁,大多数患者为女性(84.3%)。甲状腺乳头状癌最常见的变异型为滤泡型、经典型和嗜酸细胞型。大多数患者在诊断时处于 1 期(91.1%)疾病。患者(47.4%A、11.9%B、8.2%AB、32.4%O)和对照组(42%A、16%B、8%AB、34%O)的 ABO 血型分布相似(P=0.8)。就 Rh 因子而言,患者和健康对照组的特征分布相似(P=0.6)。临床和病理变量与血型分布之间没有关联(性别、年龄、肿瘤分期、肿瘤位置和病理肿瘤变异)。与健康对照组相比,甲状腺乳头状癌患者 A 血型的患病率略有增加,B 血型的患病率略有下降,但无统计学意义。此外,ABORh 血型与临床和病理变量无关。

相似文献

1
Evaluation of ABO/Rh blood group distributions in papillary thyroid cancer patients.评估甲状腺乳头状癌患者的 ABO/Rh 血型分布。
Medicine (Baltimore). 2023 Aug 11;102(32):e34564. doi: 10.1097/MD.0000000000034564.
2
ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To 'B' or Not to 'B'.ABO 血型、Rh 因子与甲状腺癌风险:“B”或不“B”。
Endocr Res. 2020 Feb-May;45(2):137-146. doi: 10.1080/07435800.2019.1695261. Epub 2019 Nov 25.
3
The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study.ABO/Rh 血型在男性乳腺癌患者中的频率及预后意义:一项多中心研究。
Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
4
Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?ABO/Rh 血型是否为多囊卵巢综合征的一个危险因素?
Medicine (Baltimore). 2023 Sep 8;102(36):e34944. doi: 10.1097/MD.0000000000034944.
5
Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer.HER2/neu阳性胃癌和胃食管交界癌患者ABO/Rh血型的分布及其预后影响
J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S747-S751. doi: 10.4103/jcrt.jcrt_1520_22. Epub 2023 May 2.
6
Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.嗜酸细胞型甲状腺乳头状癌患者的预后与匹配的经典型甲状腺乳头状癌对照患者相似。
Thyroid. 2018 Nov;28(11):1462-1467. doi: 10.1089/thy.2017.0603.
7
ABO and Rh blood groups and risk of colorectal adenocarcinoma.ABO血型和Rh血型与结肠直肠癌风险
Asian Pac J Cancer Prev. 2012;13(12):6097-100. doi: 10.7314/apjcp.2012.13.12.6097.
8
Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups.一项多中心病例对照研究中恶性间皮瘤患者的临床病理特征:ABO-Rh血型无关联
Asian Pac J Cancer Prev. 2013;14(1):249-53.
9
Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey.土耳其一项多中心研究中ABO血型与肺癌风险的关联
Asian Pac J Cancer Prev. 2013;14(5):2801-3. doi: 10.7314/apjcp.2013.14.5.2801.
10
ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.ABO 血型/Rh 因子与三阴性乳腺癌患者的发病率和结局。
Ann Surg Oncol. 2012 Oct;19(10):3159-64. doi: 10.1245/s10434-012-2533-x. Epub 2012 Aug 10.